Beta Bionics, Inc. Common Stock
BBNX • NASDAQ
Beta Bionics, Inc. Common Stock is a publicly traded company trading on NASDAQ, led by CEO Sean T. Saint, with a market cap of $477.6M.
CEOSean T. Saint
Market Cap$477.6M
Websitebetabionics.com
Next Earnings
Upcoming earnings announcement for Beta Bionics, Inc. Common Stock
Date
Tuesday, April 21, 2026 (in 3 weeks)
Timing
After Market Close (4:02 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.47
Revenue Estimate
$27.3M
Earnings History
Past 5 earnings reports for Beta Bionics, Inc. Common Stock
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | Q4 2025 | -$0.30Est: -$0.39 | +23.1% | $32.1MEst: $31.5M | +2.0% |  10-K |
| Oct 28, 2025 | Q3 2025 | -$0.33Est: -$0.43 | +23.3% | $27.3MEst: $24.0M | +13.8% | 10-Q |
| Jul 29, 2025 | Q2 2025 | -$0.39Est: -$0.48 | +18.7% | $23.2MEst: $19.7M | +17.9% | 10-Q |
| May 6, 2025 | Q1 2025 | -$0.93Est: -$0.51 | -82.4% | $17.6MEst: $16.2M | +9.2% | 10-Q |
| Mar 25, 2025 | Q4 2024 | -$2.72Est: -$0.42 | -547.6% | $20.4MEst: $20.0M | +2.1% | 10-K/A |